Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Hip Implants Market

ID: MRFR/MED/49361-HCR
200 Pages
Rahul Gotadki
Last Updated: February 06, 2026

Japan Hip Implants Market Research Report By Product Type (Total Hip Replacement Implants, Fixed-Bearing Hip Implants, Mobile-Bearing Total Hip Implants, Partial Hip Replacement Implants, Hip Resurfacing Implants, Revision Hip Replacement Implants), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers) andBy Material (Metal-on-Polyethylene, Ceramic-on-Metal, Metal-on-Metal, Ceramic-on-Polyethylene, Ceramic-on-Ceramic) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Japan Hip Implants Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Product (USD Million)
  49.     4.1.1 Total Hip implants
  50.     4.1.2 Fixed-Bearing Hip Implants
  51.     4.1.3 Mobile-Bearing Total Hip Implants
  52.     4.1.4 Partial Hip implants
  53.     4.1.5 Hip Resurfacing Implants
  54.     4.1.6 Revision Hip implants
  55.   4.2 Chemicals and Materials, BY End-User (USD Million)
  56.     4.2.1 Hospitals
  57.     4.2.2 Orthopedic Clinics
  58.     4.2.3 Ambulatory Surgical Centers
  59.   4.3 Chemicals and Materials, BY Material (USD Million)
  60.     4.3.1 Metal-on-Polyethylene
  61.     4.3.2 Ceramic-on-Metal
  62.     4.3.3 Metal-on-Metal
  63.     4.3.4 Ceramic-on-Polyethylene
  64.     4.3.5 Ceramic-on-Ceramic
  65. 5 SECTION V: COMPETITIVE ANALYSIS
  66.   5.1 Competitive Landscape
  67.     5.1.1 Overview
  68.     5.1.2 Competitive Analysis
  69.     5.1.3 Market share Analysis
  70.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  71.     5.1.5 Competitive Benchmarking
  72.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  73.     5.1.7 Key developments and growth strategies
  74.       5.1.7.1 New Product Launch/Service Deployment
  75.       5.1.7.2 Merger & Acquisitions
  76.       5.1.7.3 Joint Ventures
  77.     5.1.8 Major Players Financial Matrix
  78.       5.1.8.1 Sales and Operating Income
  79.       5.1.8.2 Major Players R&D Expenditure. 2023
  80.   5.2 Company Profiles
  81.     5.2.1 Stryker (US)
  82.       5.2.1.1 Financial Overview
  83.       5.2.1.2 Products Offered
  84.       5.2.1.3 Key Developments
  85.       5.2.1.4 SWOT Analysis
  86.       5.2.1.5 Key Strategies
  87.     5.2.2 Zimmer Biomet (US)
  88.       5.2.2.1 Financial Overview
  89.       5.2.2.2 Products Offered
  90.       5.2.2.3 Key Developments
  91.       5.2.2.4 SWOT Analysis
  92.       5.2.2.5 Key Strategies
  93.     5.2.3 DePuy Synthes (US)
  94.       5.2.3.1 Financial Overview
  95.       5.2.3.2 Products Offered
  96.       5.2.3.3 Key Developments
  97.       5.2.3.4 SWOT Analysis
  98.       5.2.3.5 Key Strategies
  99.     5.2.4 Smith & Nephew (GB)
  100.       5.2.4.1 Financial Overview
  101.       5.2.4.2 Products Offered
  102.       5.2.4.3 Key Developments
  103.       5.2.4.4 SWOT Analysis
  104.       5.2.4.5 Key Strategies
  105.     5.2.5 Medtronic (US)
  106.       5.2.5.1 Financial Overview
  107.       5.2.5.2 Products Offered
  108.       5.2.5.3 Key Developments
  109.       5.2.5.4 SWOT Analysis
  110.       5.2.5.5 Key Strategies
  111.     5.2.6 Exactech (US)
  112.       5.2.6.1 Financial Overview
  113.       5.2.6.2 Products Offered
  114.       5.2.6.3 Key Developments
  115.       5.2.6.4 SWOT Analysis
  116.       5.2.6.5 Key Strategies
  117.     5.2.7 Aesculap (DE)
  118.       5.2.7.1 Financial Overview
  119.       5.2.7.2 Products Offered
  120.       5.2.7.3 Key Developments
  121.       5.2.7.4 SWOT Analysis
  122.       5.2.7.5 Key Strategies
  123.     5.2.8 B. Braun (DE)
  124.       5.2.8.1 Financial Overview
  125.       5.2.8.2 Products Offered
  126.       5.2.8.3 Key Developments
  127.       5.2.8.4 SWOT Analysis
  128.       5.2.8.5 Key Strategies
  129.     5.2.9 Ottobock (DE)
  130.       5.2.9.1 Financial Overview
  131.       5.2.9.2 Products Offered
  132.       5.2.9.3 Key Developments
  133.       5.2.9.4 SWOT Analysis
  134.       5.2.9.5 Key Strategies
  135.     5.2.10 Wright Medical (US)
  136.       5.2.10.1 Financial Overview
  137.       5.2.10.2 Products Offered
  138.       5.2.10.3 Key Developments
  139.       5.2.10.4 SWOT Analysis
  140.       5.2.10.5 Key Strategies
  141.   5.3 Appendix
  142.     5.3.1 References
  143.     5.3.2 Related Reports
  144. 6 LIST OF FIGURES
  145.   6.1 MARKET SYNOPSIS
  146.   6.2 JAPAN MARKET ANALYSIS BY PRODUCT
  147.   6.3 JAPAN MARKET ANALYSIS BY END-USER
  148.   6.4 JAPAN MARKET ANALYSIS BY MATERIAL
  149.   6.5 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  150.   6.6 RESEARCH PROCESS OF MRFR
  151.   6.7 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  152.   6.8 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  153.   6.9 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  154.   6.10 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  155.   6.11 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 (% SHARE)
  156.   6.12 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 TO 2035 (USD Million)
  157.   6.13 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
  158.   6.14 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Million)
  159.   6.15 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 (% SHARE)
  160.   6.16 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 TO 2035 (USD Million)
  161.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  162. 7 LIST OF TABLES
  163.   7.1 LIST OF ASSUMPTIONS
  164.     7.1.1
  165.   7.2 Japan MARKET SIZE ESTIMATES; FORECAST
  166.     7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  167.     7.2.2 BY END-USER, 2025-2035 (USD Million)
  168.     7.2.3 BY MATERIAL, 2025-2035 (USD Million)
  169.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  170.     7.3.1
  171.   7.4 ACQUISITION/PARTNERSHIP
  172.     7.4.1

Japan Chemicals and Materials Market Segmentation

Chemicals and Materials By Product (USD Million, 2025-2035)

  • Total Hip implants
  • Fixed-Bearing Hip Implants
  • Mobile-Bearing Total Hip Implants
  • Partial Hip implants
  • Hip Resurfacing Implants
  • Revision Hip implants

Chemicals and Materials By End-User (USD Million, 2025-2035)

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers

Chemicals and Materials By Material (USD Million, 2025-2035)

  • Metal-on-Polyethylene
  • Ceramic-on-Metal
  • Metal-on-Metal
  • Ceramic-on-Polyethylene
  • Ceramic-on-Ceramic

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions